PTC Therapeutics

South Plainfield,  NJ 
United States
  • Booth: 401, 409

PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. EMFLAZA® (deflazacort) is the first and only FDA-approved corticosteroid indicated for the treatment of Duchenne muscular dystrophy in patients 5 years of age and older.

 Additional Info

First Time Exhibitor
For Technical Support with this webpage, please contact support.